Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Merus Labs International Inc (NASDAQ:MSLI)

0.97
Delayed Data
As of Dec 08
 0.00 / 0.00%
Today’s Change
0.81
Today|||52-Week Range
1.90
-40.85%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Other
MARKET CAP
$113.5M

Company Description

Merus Labs International, Inc. is a pharmaceutical company, which engages in the acquisition and licensing of prescription pharmaceutical products in the mature stage of the product life cycle. It operates a specialty pharmaceutical business specializing in acquisition of mature prescription and over-the-counter pharmaceutical products and licensing in of novel hospital products. The company was founded by Ahmad Doroudian on December 19, 2011 and is headquartered in Vancouver, Canada.

Contact Information

Merus Labs International, Inc.
100 Wellington Street West
Toronto Ontario M5K 1H1
P:(800) 287-7686
Investor Relations:

Employees

Shareholders

Mutual fund holders--
Individual stakeholders--
Other institutional--

Top Executives

Barry FishmanChief Executive Officer & Director
Michael BumbyChief Financial Officer
Frank RotmannVice President & Head-European Operations
Geoff MorrowVice President-Business Development
Frank FokkingaVice President-Global Regulatory Affairs